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Platelet satellitism (PS) is a rare phenomenon observed in blood smears obtained from blood anticoagulated with EDTA. It is characterised by plate-
let rosetting around polymorphonuclear neutrophils and in rare cases around other blood cells. PS is a rare cause of pseudothrombocytopenia. Refe-
rences about the phenomenon of PS in medical literature are few. In this report we describe a case of PS fortunately noticed in one trauma patient. 
Furthermore, we discuss the possible pathophysiological mechanisms of PS proposed in the literature. To our knowledge this is the fi rst case of PS 
reported in Croatia.
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Platelet satellitism (PS) is a rare in vitro phenome-
non presenting with platelets rosetting around 
polymorphonuclear neutrophils (PMN). It is ob-
served in peripheral blood smears prepared from 
blood samples anticoagulated with EDTA, but not 
in blood samples treated with heparin or sodium 
citrate (1-3). Platelet rosetting is observed mainly 
around PMN, but occasionally also around eosi-
nophils, basophils, lymphocytes or monocytes, too. 
Its clinical relevance is in the fact that it is a rare 
cause of spurious thrombocytopenia and, if not rec-
ognized, can lead to unnecessary treatment. It is 
not related to functional abnormalities of the blood, 
the patients clinical condition or to drug intake. The 
underlying mechanism of PS is not completely un-
derstood and there are a few studies trying to eluci-
date this platelet-leukocyte relationship (4).
References about PS in medical literature are few 
and not recent. There are only about a 100 cases 
described although this phenomenon is much 
more frequent, indicating that PS is not recog-
nised, or simply not reported (5). To our knowl-
edge this is the fi rst case of PS reported in Croatia.
In this case report we describe PS in a trauma pa-
tient, present an original fi gure of this phenome-
non and discuss the possible mechanisms to bet-
ter understand its nature.
Materials and methods
Case report
A 91-year-old woman was admitted to the Univer-
sity Hospital of Traumatology because of a left 
femoral fracture. Previous clinical history included 
senile dementia, deafness and blindness, and arte-
rial hypertension. The patient was on hyperten-
sion therapy and “other drugs”, but because of her 
physical and mental condition, detailed informa-
tion about previous medication intake could not 
be obtained. Immediately after admission, the pa-
tient was prepared for surgery, including preoper-
ative laboratory workup (biochemistry, hematolo-
gy and blood coagulation) and underwent surgery 
the same day. During surgery patient developed a 
myocardial infarction and respiratory failure and 
was admitted to the intensive care unit (ICU) for 
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further treatment. In the ICU, patient received anti-
biotic prophylaxis; antiparkinsonic, thrombopro-
phylactic, antiulcer and analgesic therapy continu-
ously, and volume replacement therapy. On the 1st 
and 5th day of ICU stay the patient received trans-
fusion therapy (packed red blood cells). She devel-
oped a urinary tract infection and was treated with 
antibacterial therapy (norfl oxacin) during the 
whole period of hospitalization. On the 5th day of 
ICU stay she developed a re-infarction and was 
treated for it. The patient was discharged the 26th 
day of ICU stay.
Methods
Routine laboratory analyses (biochemistry, hema-
tology, blood coagulation) were performed on the 
patient samples daily for monitoring purposes. A 
portion of the serum sample taken on the 7th, 8th 
and 9th day of ICU stay was frozen at -20°C for IgG 
concentration testing. Whole blood samples taken 
on K3EDTA were analysed upon receipt on the au-
tomated hematology analyser Sysmex XT-1800i 
(Sysmex Corporation, Kobe, Japan). Prior to the dis-
covery of PS, the sodium citrate tubes were sam-
pled for routine coagulation analyses. After detec-
tion of the PS phenomenon, if whole blood on so-
dium citrate for blood coagulation was not sam-
pled, we requested sampling, for comparison pur-
poses. The platelet count obtained with sodium 
citrate on the hematology analyser was multiplied 
by 1.1 (dilution factor). Blood smears were stained 
manually, using the May-Grunwald-Giemsa (MGG) 
stain. Blood smears were studied using light mi-
croscopy and the degree of PS was estimated 
(PMN involved in PS per 100 counted PMN) (6). IgG 
concentration was determined on the Olympus 
AU2700 automated chemistry analyser (Olympus 
corporation, Shizuoka, Japan) at the University De-
partment of Chemistry, Medical School University 
Hospital Sestre Milosrdnice, Zagreb.
Results
The hematological fi ndings displayed through the 
patient stay in the ICU are in accordance with the 
patients pathological condition (Table 1). On the 
fi rst and 5th day of ICU stay, complete blood count 
and smear analysis were requested, and no throm-
bocytopenia nor satellitism were noticed. Howev-
er, during a requested blood smear analysis on her 
7th day of ICU stay, we accidentally discovered the 
phenomenon of PS. The blood cell count with dif-
ferential cell count performed on the automated 
hematology analyser, and in particular the platelet 
count, indicated no peculiarities and the analyser 
gave no warning signals (fl ags). It is after perform-
ing the blood smear analysis by light microscope, 
that we noticed the PS. Most of the PMN were sur-
rounded by platelets, leaned onto their mem-
branes (Figure 1). The satellitism was limited to 
blood samples anticoagulated with K3EDTA, be-
cause blood smears made from blood anticoagu-
lated with sodium citrate showed absence of plate-
let satellitism. Also, the platelets seemed to adhere 
exclusively on PMN neutrophils.
The next day (8th day of ICU stay) PS was still 
present, but was visibly reduced and still absent in 
smears from blood anticoagulated with sodium ci-
trate. On the 9th day of ICU stay and during the re-
maining period of the patient stay in the ICU, the 
PS phenomenon was no longer present in the 
blood smear.
Interestingly, although PS has been reported as a 
cause of pseudothrombocytopenia, in our case 
the platelet count showed no important change in 
terms of thrombocytopenia even on day 7 of ICU 
stay, when the PS was most pronounced. The 
FIGURE 1. Platelet satellitism in EDTA anticoagulated blood.
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Day 1 Day 7 Day 8 Day 9 Day 11 Reference range
RBC (1012/L) 4.13 4.16 4.21 4.09 3.85 3.86-5.08
MCV (fL) 86.2 85.1 86.5 87.8 87.5 83.0-97.2
MCH (pg) 26.9 27.4 27.1 27.1 27.3 27.4-33.9
HGB (g/L) 111 114 114 111 105 119-157
PLT K3EDTA (109/L) 259 286 342 369 391 158-424
PLT Na citrate (109/L) - 330 369 - -
MPV (fL) 10.4 10.2 10.0 10.1 10.0 6.8-10.4
WBC (109/L) 17.4 13.6 13.3 13.6 14.8 3.4-9.7
PMN (109/L) - 10.42 10.38 - - 2.06-6.49
IgG (g/L) - 4.99 4.79 5.21 - 7-16
Degree of PS (%) - 62 15 - - -
RBC - red blood cells; MCV - mean corpuscular volume; MCH - mean corpuscular hemoglobin; HGB – hemoglobin; PLT – platelets; K3EDTA – po-
tassium-3-ethylenediaminetetraacetic acid; MPV - mean platelet volume; WBC - white blood cells; PMN - polymorphonuclear neutrophils; PS - 
platelet satellitism.
TABLE 1. Laboratory fi ndings during the patient ICU stay 
platelet count observed on the 7th and 8th day of 
ICU stay was lower in specimens collected on 
K3EDTA in comparison to specimens collected on 
citrate due to the present PS (Table 1).
The transient nature of the PS observed in our case 
unfortunately did not allow any further investiga-
tion of the phenomenon.
Discussion
Platelet satellitism (PS) was fi rst reported in 1963 
by Field and McLeod and to date about a 100 cas-
es have been reported (5,6). PS is defi ned as an in 
vitro phenomenon of platelets rosetting around 
neutrophils, occuring in blood samples anticoagu-
lated only with K3EDTA at room temperature. With 
few exceptions, it occurs mainly with PMN (7-10). 
In agreement with previously published data, we 
found PS only around PMN and only in samples 
anticoagulated with K3EDTA.
PS has been observed in normal individuals and in 
association with a variety of disease conditions, so 
it is independent from pathologic processes that 
brought the patient to the hospital (6,8).
The pathophysiological nature of PS still remains 
to be elucidated, although some possible mecha-
nisms have been reported. Published data indicate 
that PS activity is easily transferred by incubating 
PS-patient EDTA-plasma or serum, with EDTA anti-
coagulated blood from subjects with no PS. Fur-
thermore, PS activity in plasma can be annulled by 
prior incubation with anti-IgG serum, but not with 
anti-IgM or anti-IgA. In addition, the PS phenome-
non can be reproduced if IgG-containing eluate 
after chromatographic immunopurifi cation is in-
cubated with normal subject samples. This dem-
onstrates that PS is mediated by an IgG antibody 
and that the presence of EDTA is essential (6,11). 
Bizzaro et al. showed that, by incubating the PS 
patient sample with monoclonal antibodies anti-
FcγRIII (CD16) and anti-glycoprotein IIb/IIIa, the oc-
curence of PS can be completely blocked. They 
demonstrated also that no PS can be detected 
when PS-plasma was incubated with blood from 
subjects with type I Glanzmann thrombastenia 
(platelets lack glycoprotein IIb/IIIa complex) or 
congenital FcγRIII defi ciency on neutrophils. In 
conclusion, their results suggest that the IgG anti-
bodies formed in PS-subjects are directed against 
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the platelet GP IIb/IIIa complex and the neutrophil 
FcγRIII (6). The working hypothesis of the PS phe-
nomenon is that EDTA, by chelating Ca2+ ions, 
changes the platelet membrane and unmasks 
(crypto)antigenic structures on platelet GPIIb/IIIa 
and PMN neutrophils, and then the IgG recognises 
them forming a bridge between the two cells. Why 
PS-patients produce these IgG (auto)antibodies 
and what is the mechanism of their interaction 
with target molecules on platelet and PMN mem-
branes, is still unclear (11,12). Some authors sug-
gest that thrombospondin, an α-granule protein 
involved in intercellular interactions, could be the 
cytoadhesive protein essential for PS development 
(13). Unfortunately, we can only speculate about 
the mechanism of developement of PS in our case. 
The most probable hypothesis is the immunologi-
cal route, via formation of antibodies that caused 
platelets to target neutrophil membranes (and vice 
versa). The trigger that possibly instigated the for-
mation of antibodies could be the drug therapy or, 
more likely, the transfusion therapy received in the 
ICU. Transfusion therapy was applied on two con-
secutive occasions in our patient (on the 5th day a 
double dose) and the PS appeared two days after 
that. If the underlying mechanism was immuno-
logical in nature, it is possible that it was just a mild 
reaction that rapidly attenuated, explaining the 
sudden disappearance of the PS phenomenon. For 
complete elucidation of the PS mechanism further 
investigations are needed.
PS is clinically relevant as a possible cause of spuri-
ous thrombocytopenia. It is not associated with 
platelet dysfuction or hemorrhagic diathesis. 
When PS occurs, platelet counts are moderately 
reduced (from 50-100 x 109/L) leading to pseudo-
thrombocytopenia or not, like in our patient. Even 
if on the 7th day of ICU stay the degree of PS was 
62%, thrombocytopenia was not detected be-
cause the number of platelet rosetting around 
neutrophils varied (from 3-5 to 15-20).
Failure of recognizing PS as the cause of pseudo-
thrombocytopenia can lead to unnecessary labo-
ratory testing, delay of surgery and needless trans-
fusions or bone marrow aspirations. Even though 
automated hematology analysers are of wide-
spread use in clinical laboratories, they are not al-
ways reliable in reporting error fl ags that could in-
stigate suspicion. However, a simple means of ex-
cluding pseudothrombocytopenia, and thus PS, in 
the operative setting is the simultaneous collec-
tion of blood with two anticoagulants, EDTA and 
citrate, and comparison of platelet counts ob-
tained from both specimens. Furthermore, a pe-
ripheral blood smear provides defi nitive evidence 
of pseudothrombocytopenia caused by PS. Per-
forming a blood smear from the citrate-anticoagu-
lated blood and/or a fi ngertip smear will show no 
platelet rosseting around PMN, which is an addi-
tional confi rmation of the presence of PS.
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Satelitizam trombocita kod bolesnika s traumom
Sažetak
Satelitizam trombocita (engl. platelet satellitism, PS) rijedak je fenomen primijećen u razmazima krvi tretirane antikoagulansom EDTA. Karakteri-
ziran je formacijom trombocita u obliku rozete oko polimorfonuklearnih neutrofi la i u rijetkim slučajevima oko drugih krvnih stanica. PS je rijedak 
uzrok pseudotrombocitopenije. U literaturi postoji malo referenci o PS. U ovom članku izvještavamo o slučaju PS koji je na sreću primijećen kod 
jednog pacijenta s traumom. Nadalje, raspravljamo o mogućim patofi ziološkim mehanizmima PS koji se mogu naći u literaturi. Koliko znamo, ovo 
je prvi slučaj PS prijavljen u Hrvatskoj.
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